Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   EBIT Growth(%) 72.7428.206.6673.35-0.16

What is the latest EBIT Growth ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EBIT Growth ratio of SYNCOM FORMULATIONS (INDIA) is 72.74 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202572.74
Mar202428.20
Mar20236.66
Mar202273.35
Mar2017-0.16

How is EBIT Growth of SYNCOM FORMULATIONS (INDIA) Trending?

Years EBIT Growth % Change
Mar2025 72.74
157.94
Mar2024 28.2
323.42
Mar2023 6.66
-90.92
Mar2022 73.35
Positive
Mar2017 -0.16 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EBIT Growth ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,551.0 Cr -0.6% 2.3% -14.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,452.0 Cr -0.3% 6% -10.5% Stock Analytics
DIVIS LABORATORIES ₹179,089.0 Cr 3.9% 18.6% 14.5% Stock Analytics
CIPLA ₹121,299.0 Cr -5.2% NA 2.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,456.0 Cr -1% -1.2% 8.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,965.9 Cr -6.8% -2.1% -8.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-0.6%

2.3%

-14.6%

SENSEX

-0.3%

4.5%

5.7%


You may also like the below Video Courses